Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2015 02:34 ET | Source: Galapagos NV

Galapagos raises EU5.8 million through warrant exercises, Board and Executive Committee members invest

MECHELEN, Belgium, March 27, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today a share capital increase arising from warrant exercises. Board members invest €2.1...
February 11, 2015 01:33 ET | Source: Galapagos NV

Galapagos receives EU1.6 million IWT grant for hepatitis B program

MECHELEN, Belgium, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announces that the Flemish Agency for Innovation through Science and Technology (IWT) has awarded a...
January 22, 2015 01:36 ET | Source: Galapagos NV

Galapagos receives EU2.5 million IWT grant for antibiotic research

MECHELEN, Belgium, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announces that the Flemish Agency for Innovation through Science and Technology (IWT) has awarded a...
December 19, 2014 01:44 ET | Source: Galapagos NV

Galapagos initiates first Phase 1 study in cystic fibrosis and will receive milestone payment from AbbVie

MECHELEN, Belgium, Dec. 19, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announces the initiation of the first Phase 1 study with GLPG1837. This novel potentiator is designed as a CFTR...
October 27, 2014 02:39 ET | Source: Galapagos NV

Galapagos and Calchan collaborate on osteoarthritis research, PS2.4 million grant awarded by Innovate UK

MECHELEN, Belgium and CAMBRIDGE, United Kingdom, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG), a clinical stage biotech company focused on developing novel mode of action medicines,...
August 08, 2014 01:42 ET | Source: Galapagos NV

Galapagos cash position of EU232 M provides solid basis for R&D pipeline investment

Net profit of €56 M for first half 2014 Solid cash balance of €232 M on 30 June 2014, liquid assets position of €240 M Group revenues €63 M, including...
July 04, 2014 12:07 ET | Source: Galapagos NV

Galapagos raises EU1.9 million through warrant exercises

MECHELEN, Belgium, July 4, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today a share capital increase arising from warrant exercises. Since its inception in 1999, Galapagos has...
July 01, 2014 01:37 ET | Source: Galapagos NV

Galapagos initiates Phase 1 study with GLPG1690, triggering EU6.6 M milestone in the alliance with Janssen Pharmaceutica NV

Mechelen, Belgium, July 1, 2014 (GLOBE NEWSWIRE) -- Mechelen, Belgium; 1 July 2014 - Galapagos NV (Euronext: GLPG) announced today that GLPG1690, a first-in-class molecule aimed at treating pulmonary...
April 10, 2014 12:05 ET | Source: Galapagos NV

Galapagos raises EU2.4 million through warrant exercises

Mechelen, Belgium, April 10, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext:GLPG) announced today a share capital increase arising from warrant exercises. Since its inception in 1999, Galapagos...
March 13, 2014 02:53 ET | Source: Galapagos NV

Charles River Laboratories to acquire Galapagos' Argenta and BioFocus service operations for up to EU134 million

· Total cash consideration of up to €134 million o €129 million cash payment o earnout of €5 million upon achievement...